This Oncology Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The oncology devices market size has grown rapidly in recent years. It will grow from $150.3 billion in 2024 to $178.95 billion in 2025 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to rising prevalence of cancer, growing aging population, increasing demand for personalized cancer treatments, genomic profiling.
The oncology devices market size is expected to see rapid growth in the next few years. It will grow to $346.48 billion in 2029 at a compound annual growth rate (CAGR) of 18%. The growth in the forecast period can be attributed to minimally invasive surgical techniques, biodegradable implants, global expansion of healthcare, value-based care models, digital health integration. Major trends in the forecast period include advancements in radiation therapy, early detection technologies, advancements in oncology devices, liquid biopsies, ai-powered decision support.
The increasing prevalence of cancer worldwide is expected to drive the demand for the oncology devices market. Cancer remains a significant global health challenge and is the second leading cause of death in the United States. The rising incidence of cancer has led to growing demand for oncology devices to support the treatment and care of cancer patients. For example, in October 2022, Macmillan Cancer Support, a UK-based healthcare charity, projected that the number of people living with cancer in the UK will reach 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the rising cancer incidence is also expected to propel the demand for the oncology drugs market.
The growing demand for chemotherapy is set to propel the oncology devices market's expansion. Chemotherapy is a systemic treatment method targeting rapidly dividing cells, including cancer cells. Oncology devices play a crucial role in chemotherapy by ensuring precise drug delivery, reducing systemic toxicity and side effects, and enhancing treatment effectiveness. For example, projections from Healthcare IT News in February 2022 suggest that the demand for cancer chemotherapy will rise from 10 million to 15 million by 2040. Hence, the increasing need for chemotherapy is a driving force behind the growth of the oncology devices market.
Leading companies in the oncology devices market are actively focusing on innovative products like the benchmark ultra plus system to enhance their revenues. The benchmark ultra plus system is an integrated, fully automated platform used in pathology and diagnostic laboratories for various laboratory processes, including sample and slide preparation, staining, and imaging. In June 2022, F. Hoffmann-La Roche AG, a Swiss healthcare company specializing in oncology devices, launched the benchmark ultra plus system. This system comes with several improvements, such as user-friendly software, remote monitoring capabilities, an integrated touchscreen for an enhanced user experience, and more eco-friendly waste management and product packaging. These enhancements enable the system to provide high-quality and timely results to physicians and patients by optimizing workflow, testing efficiency, and environmental sustainability.
Prominent companies in the market, alongside research institutions and governments, maintain a steadfast commitment to developing novel devices for the treatment of cancer patients. A prime example of such innovation is AIROS Medical Inc., a USA-based medical technology company, which introduced the AIROS 6 sequential compression therapy device and garment system designed to aid breast cancer patients. This advanced technology has expanded treatment options for upper extremity post-mastectomy care, particularly for patients dealing with lymphedema.
In March 2024, Halma PLC, a UK-based company specializing in life-saving technologies that prevent injuries, save lives, and protect people and assets, acquired Rovers Medical Devices B.V. for $93.5 million. This acquisition is intended to expand Halma PLC's market presence in women's health and enhance its capabilities in cancer diagnostics. Rovers Medical Devices B.V. is a Netherlands-based company focused on designing, developing, and manufacturing medical devices for cancer screening.
Oncology devices are specialized medical devices utilized for the diagnosis, management, and treatment of cancer.
The primary device categories within the field of oncology devices include brachytherapy devices and endoscopic devices. Endoscopic devices serve a critical role in the diagnosis, management, and treatment of cancer by allowing healthcare professionals to visually inspect the internal body cavities and organs for abnormalities. These devices find applications in various cancer therapies, including chemotherapy, hormone therapy, biotherapy/immunotherapy, and radiation therapy. They are employed by a range of end-users, including hospitals, cancer research institutes, and other medical facilities dedicated to cancer care and research.
The oncology devices market research report is one of a series of new reports that provides oncology devices market statistics, including oncology devices industry global market size, regional shares, competitors with a oncology devices market share, detailed oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the oncology devices industry. This oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major companies operating in the oncology devices market include Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic PLC, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.
North America was the largest region in the oncology devices market in 2024. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the oncology devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The oncology devices market consists of sales of brachytherapy devices and endoscopic devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The oncology devices market size has grown rapidly in recent years. It will grow from $150.3 billion in 2024 to $178.95 billion in 2025 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to rising prevalence of cancer, growing aging population, increasing demand for personalized cancer treatments, genomic profiling.
The oncology devices market size is expected to see rapid growth in the next few years. It will grow to $346.48 billion in 2029 at a compound annual growth rate (CAGR) of 18%. The growth in the forecast period can be attributed to minimally invasive surgical techniques, biodegradable implants, global expansion of healthcare, value-based care models, digital health integration. Major trends in the forecast period include advancements in radiation therapy, early detection technologies, advancements in oncology devices, liquid biopsies, ai-powered decision support.
The increasing prevalence of cancer worldwide is expected to drive the demand for the oncology devices market. Cancer remains a significant global health challenge and is the second leading cause of death in the United States. The rising incidence of cancer has led to growing demand for oncology devices to support the treatment and care of cancer patients. For example, in October 2022, Macmillan Cancer Support, a UK-based healthcare charity, projected that the number of people living with cancer in the UK will reach 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the rising cancer incidence is also expected to propel the demand for the oncology drugs market.
The growing demand for chemotherapy is set to propel the oncology devices market's expansion. Chemotherapy is a systemic treatment method targeting rapidly dividing cells, including cancer cells. Oncology devices play a crucial role in chemotherapy by ensuring precise drug delivery, reducing systemic toxicity and side effects, and enhancing treatment effectiveness. For example, projections from Healthcare IT News in February 2022 suggest that the demand for cancer chemotherapy will rise from 10 million to 15 million by 2040. Hence, the increasing need for chemotherapy is a driving force behind the growth of the oncology devices market.
Leading companies in the oncology devices market are actively focusing on innovative products like the benchmark ultra plus system to enhance their revenues. The benchmark ultra plus system is an integrated, fully automated platform used in pathology and diagnostic laboratories for various laboratory processes, including sample and slide preparation, staining, and imaging. In June 2022, F. Hoffmann-La Roche AG, a Swiss healthcare company specializing in oncology devices, launched the benchmark ultra plus system. This system comes with several improvements, such as user-friendly software, remote monitoring capabilities, an integrated touchscreen for an enhanced user experience, and more eco-friendly waste management and product packaging. These enhancements enable the system to provide high-quality and timely results to physicians and patients by optimizing workflow, testing efficiency, and environmental sustainability.
Prominent companies in the market, alongside research institutions and governments, maintain a steadfast commitment to developing novel devices for the treatment of cancer patients. A prime example of such innovation is AIROS Medical Inc., a USA-based medical technology company, which introduced the AIROS 6 sequential compression therapy device and garment system designed to aid breast cancer patients. This advanced technology has expanded treatment options for upper extremity post-mastectomy care, particularly for patients dealing with lymphedema.
In March 2024, Halma PLC, a UK-based company specializing in life-saving technologies that prevent injuries, save lives, and protect people and assets, acquired Rovers Medical Devices B.V. for $93.5 million. This acquisition is intended to expand Halma PLC's market presence in women's health and enhance its capabilities in cancer diagnostics. Rovers Medical Devices B.V. is a Netherlands-based company focused on designing, developing, and manufacturing medical devices for cancer screening.
Oncology devices are specialized medical devices utilized for the diagnosis, management, and treatment of cancer.
The primary device categories within the field of oncology devices include brachytherapy devices and endoscopic devices. Endoscopic devices serve a critical role in the diagnosis, management, and treatment of cancer by allowing healthcare professionals to visually inspect the internal body cavities and organs for abnormalities. These devices find applications in various cancer therapies, including chemotherapy, hormone therapy, biotherapy/immunotherapy, and radiation therapy. They are employed by a range of end-users, including hospitals, cancer research institutes, and other medical facilities dedicated to cancer care and research.
The oncology devices market research report is one of a series of new reports that provides oncology devices market statistics, including oncology devices industry global market size, regional shares, competitors with a oncology devices market share, detailed oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the oncology devices industry. This oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major companies operating in the oncology devices market include Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic PLC, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.
North America was the largest region in the oncology devices market in 2024. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the oncology devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The oncology devices market consists of sales of brachytherapy devices and endoscopic devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Oncology Devices Market Characteristics3. Oncology Devices Market Trends and Strategies4. Oncology Devices Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market68. Global Oncology Devices Market Competitive Benchmarking and Dashboard69. Key Mergers and Acquisitions in the Oncology Devices Market70. Recent Developments in the Oncology Devices Market
5. Global Oncology Devices Growth Analysis and Strategic Analysis Framework
6. Oncology Devices Market Segmentation
7. Oncology Devices Market Regional and Country Analysis
8. Asia-Pacific Oncology Devices Market
9. China Oncology Devices Market
10. India Oncology Devices Market
11. Japan Oncology Devices Market
12. Australia Oncology Devices Market
13. Indonesia Oncology Devices Market
14. South Korea Oncology Devices Market
15. Bangladesh Oncology Devices Market
16. Thailand Oncology Devices Market
17. Vietnam Oncology Devices Market
18. Malaysia Oncology Devices Market
19. Singapore Oncology Devices Market
20. Philippines Oncology Devices Market
21. Hong Kong Oncology Devices Market
22. New Zealand Oncology Devices Market
23. Western Europe Oncology Devices Market
24. UK Oncology Devices Market
25. Germany Oncology Devices Market
26. France Oncology Devices Market
27. Italy Oncology Devices Market
28. Spain Oncology Devices Market
29. Spain Oncology Devices Market
30. Austria Oncology Devices Market
31. Belgium Oncology Devices Market
32. Denmark Oncology Devices Market
33. Finland Oncology Devices Market
34. Ireland Oncology Devices Market
35. Netherlands Oncology Devices Market
36. Norway Oncology Devices Market
37. Portugal Oncology Devices Market
38. Sweden Oncology Devices Market
39. Switzerland Oncology Devices Market
40. Eastern Europe Oncology Devices Market
41. Russia Oncology Devices Market
42. Czech Republic Oncology Devices Market
43. Poland Oncology Devices Market
44. Romania Oncology Devices Market
45. Ukraine Oncology Devices Market
46. North America Oncology Devices Market
47. USA Oncology Devices Market
48. Canada Oncology Devices Market
50. South America Oncology Devices Market
51. Brazil Oncology Devices Market
52. Chile Oncology Devices Market
53. Argentina Oncology Devices Market
54. Colombia Oncology Devices Market
55. Peru Oncology Devices Market
56. Middle East Oncology Devices Market
57. Saudi Arabia Oncology Devices Market
58. Israel Oncology Devices Market
59. Iran Oncology Devices Market
60. Turkey Oncology Devices Market
61. United Arab Emirates Oncology Devices Market
62. Africa Oncology Devices Market
63. Egypt Oncology Devices Market
64. Nigeria Oncology Devices Market
65. South Africa Oncology Devices Market
66. Oncology Devices Market Competitive Landscape and Company Profiles
67. Oncology Devices Market Other Major and Innovative Companies
71. Oncology Devices Market High Potential Countries, Segments and Strategies
72. Appendix
Executive Summary
Oncology Devices Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on oncology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for oncology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oncology devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Device Type: Brachytherapy Devices; Endoscopic Devices2) By Therapy: Chemotherapy; Hormone Therapy; Biotherapy/Immunotherapy; Radition Therapy
3) By End User: Hospitals; Cancer Research Institutes; Other End Users
Subsegments:
1) By Brachytherapy Devices: Afterloaders (High-Dose Rate (HDR) And Low-Dose Rate (LDR)); Applicators; Seeds; Accessories2) By Endoscopic Devices: Endoscopes (Flexible, Rigid, Capsule); Endoscopic Ultrasound Systems; Endoscopic Accessories
Key Companies Mentioned: Eckert & Ziegler BEBIG GmbH; Oncura Inc.; GE Healthcare; Medtronic plc; Varian Medical Systems Inc.
Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this Oncology Devices market report include:- Eckert & Ziegler BEBIG GmbH
- Oncura Inc.
- GE Healthcare
- Medtronic plc
- Varian Medical Systems Inc.
- Elekta AB
- Theragenics Corporation
- Accuray Incorporated
- Roche Diagnostics
- IBA Group
- Biogenex Laboratories
- Becton Dickinson and Company
- Siemens Healthineers
- Philips Healthcare
- Hologic Inc.
- IBA AG
- ViewRay Inc.
- Canon Medical Systems Corporation
- Brainlab
- PerkinElmer
- RaySearch Laboratories
- Mevion Medical Systems
- Vision RT
- IsoRay
- RefleXion Medical
- Alpha Tau Medical
- Nanobiotix
- Mirada Medical Ltd.
- Navidea Biopharmaceuticals Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | April 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 178.95 Billion |
| Forecasted Market Value ( USD | $ 346.48 Billion |
| Compound Annual Growth Rate | 18.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
